Why is Fischer Medical falling/rising?

As of 25-Aug, Fischer Medical Ventures Ltd's stock price is rising, currently at 1,074.00, reflecting an increase of 16.0 (1.51%). The stock has recently hit a new 52-week high of Rs. 1080 and has been on a consecutive gain streak for the last seven days, resulting in a total return of 12.43% during this period. The company has demonstrated strong performance with a significant growth in net sales of 247.89% and a remarkable increase in profit before tax, which has contributed to its positive outlook. Despite a low return on equity of 1.39% and a high price-to-book value, the stock's consistent returns over the past three years and low debt-to-equity ratio suggest a solid investment opportunity, although concerns about management efficiency and profitability remain.
In the broader market context, Fischer Medical has significantly outperformed the benchmark Sensex, with a 1-week return of +4.83% compared to the benchmark's +0.45%, and a year-to-date return of +51.41% against the Sensex's +4.48%. This strong performance indicates that investor confidence in Fischer Medical is robust, particularly in light of its recent financial results and rising investor participation. The stock's liquidity and trading volume further support its upward movement, suggesting that market sentiment is favorable despite the underlying risks associated with management efficiency and valuation concerns.